Post-approval studies (Phase 4)Enrolling By InvitationNCT06660329
What this trial is testing
Efficacy and Safety of Tofacitinib in Refractory Blau Syndrome
Who this might be right for
Blau Syndrome
Peking Union Medical College Hospital 30
Showing 5 of 5 results